Why has NICE said this?
NICE looks at how well treatments work in relation to how much they cost compared with other treatments available on the NHS.
Sofosbuvir (with peginterferon alfa and ribavirin, or ribavirin alone) was recommended as a possible treatment for some types of chronic hepatitis C. This is because the benefits to patients justify its cost for these types of chronic hepatitis C.